Document text
Principal Investigator: DAVID B. WEINER
Organization: INTERNATIONAL SOCIETY OF VACCINES
Fiscal Year: 2023
Award: $5,000
Funding agency: National Institute of Allergy and Infectious Diseases
Project Summary / Abstract
The International Society for Vaccines (ISV) is a not-for-profit membership organization founded
in 1992 with members from 44 countries, holding annual congresses since 2007. With the ISV
Annual Congress, attended by member and non-member participants from 5 continents, the
Society aims to highlight the very latest ground-breaking developments in vaccine research,
manufacturing, clinical development and implementation, and safety. Plenary sessions are
devoted to current hot topics spanning diverse areas of vaccinology, including vaccines against
challenging targets, T-cell based vaccines, B cell memory establishment, structure-based
vaccine design, mucosal vaccines, and vaccines against emerging infectious diseases. The ISV
Congress, as the main comprehensive non-commercial vaccine meeting, strives to ensure
participation of speakers and delegates from a diverse background (academic, industry,
government, and foundations). Breakout sessions include topics related to adjuvant
mechanisms, One Health, vaccines against zoonotic infections, and next generation vaccines.
Renowned invited speakers in these fields have been and will be invited to set the stage for
each of the plenary topics, complemented with oral presentations selected from the submitted
abstracts. The program will also provide a forum for the next generation of scientists who are
active in the vaccinology field, to present their data in oral or poster presentations, discuss with
peers and senior scientists, and advance their careers, be it in academia, industry, or
government. ISV’s Bright Sparks in Vaccinology competition acknowledges student and postdoc
presentations in parallel sessions of the oral program to support the participation and careers of
next generation vaccinologists. To strengthen their professional advancements, the ISV
Congress, building on its long-standing commitment to mentoring, dedicate a session to career
development opportunities, bringing together junior and senior scientists in an interactive
atmosphere. To stimulate the participation of young scientists, which has always been
successful in the past, the ISV has a policy of inexpensive registration rates for PhD students
and provides Travel Awards to selected junior scientists (based upon abstract submission and
review for quality) to help defray costs of in-person and virtual participation. Prizes for best
presentations or oral abstracts and poster abstracts are a high priority of the ISV Officers, who
volunteer to review and rank all presentations during the ongoing conference to select winners
and runners up based on abstract quality and presentation skills, and present award certificates
to the prize winners.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><A baumanni><A baumannii><A. baumanni><A. baumannii><A.baumannii><Academia><Acinetobacter baumanni><Acinetobacter baumannii><Address><Adjuvant><African Swine Fever Virus><Animal Model><Animal Models and Related Studies><Antibody Affinity><Antibody Response><Antigenic Determinants><Antigens><Antineoplastic Vaccine><Area><Award><B blood cells><B cell><B cells><B-Cell Epitopes><B-Cells><B-Lymphocyte Epitopes><B-Lymphocytes><B-cell><Binding Determinants><Blood Plasma Cell><Bone Marrow><Bone Marrow Reticuloendothelial System><Business-Friendly Atmosphere><COVID-19><COVID-19 infection><COVID-19 vaccine><COVID-19 virus><COVID-19 virus infection><COVID19><COVID19 infection><COVID19 vaccine><COVID19 virus><CV-19><CV19><Cancer Vaccines><Cancers><Cell Surface Antigens><Cell-Mediated Lympholytic Cells><Childhood><Clinic><Clinical><Clinical Treatment Moab><CoV-2><CoV2><Communicable Diseases><Complement><Complement Proteins><Complex><Congresses><Country><Cytolytic T-Cell><Cytotoxic T Cell><Cytotoxic T-Lymphocytes><Data><Dedications><Dengue><Development><Disease><Disorder><Emerging Communicable Diseases><Emerging Infectious Diseases><Ensure><Epitopes><Event><Foundations><Generations><Government><HIV Envelope Glycoprotein gp120><HIV Envelope Protein gp120><HIV env Protein gp120><HIV-1><HIV-I><HIV1><HTLV-III gp120><Health><Health Care Systems><Healthcare Systems><Helper Cells><Helper T-Cells><Helper T-Lymphocytes><Helper-Inducer T-Cells><Helper-Inducer T-Lymphocyte><Human><Human Immunodeficiency Virus Type 1><Human immunodeficiency virus 1><Immune><Immune memory><Immune response><Immunes><Immunization Programs><Immunologic Memory><Immunologic Surface Markers><Immunological Memory><Immunological Surface Markers><Immunological response><Immunology><Incidence><Inducer Cells><Inducer T-Lymphocytes><Industry><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Influenza Virus><International><Knowledge><Lead><Learning><Licensing><Malaria><Malaria Vaccines><Malarial Vaccines><Malignant Cell><Malignant Neoplasms><Malignant Tumor><Medical><Memory B Cell><Memory B-Lymphocyte><Mentors><Messenger RNA><Modern Man><Molecular Configuration><Molecular Conformation><Molecular Stereochemistry><Monoclonal Antibodies><Mucosa><Mucosal Immunity><Mucosal Tissue><Mucous Membrane><Multi-Drug Resistance><Multidrug Resistance><Multiple Anti-bacterial Drug Resistance><Multiple Anti-bacterial Drug Resistant><Multiple Antibacterial Drug Resistance><Multiple Antibacterial Drug Resistant><Multiple Bacterial Drug Resistance><Multiple Drug Resistance><Multiple Drug Resistant><Neoplasm Vaccines><Oral><P falciparum><P. falciparum><P.falciparum><Paludism><Parasites><Participant><Pb element><Persons><Ph D student><Ph D. student><Ph. D. student><Ph.D student><Ph.D. student><PhD student><PhD. student><Phenotype><Plasma Cells><Plasmacytes><Plasmodium Infections><Plasmodium falciparum><Policies><Postdoc><Postdoctoral Fellow><Preparation><Prize><RNA vaccine><RNA-based vaccine><Research><Research Associate><Resistance to Multi-drug><Resistance to Multidrug><Resistance to Multiple Anti-bacterial Drug><Resistance to Multiple Antibacterial Drug><Resistance to Multiple Drug><Resistant to Multiple Anti-bacterial Drug><Resistant to Multiple Antibacterial Drug><Resistant to Multiple Drug><Resistant to multi-drug><Resistant to multidrug><Respiratory syncytial virus F protein><Respiratory syncytial virus RSV F proteins><Role><S pyogenes><S. pyogenes><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 infection><SARS-CoV-2 vaccine><SARS-CoV2><SARS-CoV2 infection><SARS-CoV2 vaccine><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Safety><Scientist><Senior Scientist><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Site><Societies><Speed><Streptococcus Group A><Streptococcus pyogenes><Structure><Students><Surface Antigens><Switzerland><System><T-Cells><T-Lymphocyte><T-cell receptor repertoire><TCR repertoire><Technology><Travel><Tumor Vaccines><Vaccination Programs><Vaccine Antigen><Vaccine Design><Vaccine Research><Vaccines><Variant><Variation><Viral Latency><Viral reservoir><Virus Latency><Virus reservoir><Virus-like particle><Wart-Hog Disease Virus><Wuhan coronavirus><Zoonoses><Zoonotic><Zoonotic Infection><anamnestic reaction><anti-tumor vaccine><antigen antibody affinity><antitumor vaccine><business-friendly environment><cancer cell><career><career development><chronic infection><clinical development><clinical implementation><collaborative atmosphere><collaborative environment><conference><conformation><conformational><conformational state><conformationally><conformations><convention><corona virus disease 2019><corona virus disease 2019 vaccine><coronavirus disease 2019><coronavirus disease 2019 infection><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease-19><coronavirus disease-19 vaccine><coronavirus disease-19 virus><coronavirus infectious disease-19><cost><cost effective><design><designing><developmental><doctoral student><expectation><fighting><gp120><gp120 ENV Glycoprotein><gp120(HIV)><hCoV19><health care organization><health care service organization><healthcare organization><healthcare service organization><heavy metal Pb><heavy metal lead><host response><immune system response><immunization strategy><immunogen><immunoresponse><improved><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><influenzavirus><insight><interactive atmosphere><interactive environment><interdisciplinary atmosphere><interdisciplinary environment><killer T cell><life-threatening COVID><life-threatening COVID-19><life-threatening SARS-CoV-2><life-threatening coronavirus disease><life-threatening coronavirus disease 2019><life-threatening severe acute respiratory syndrome coronavirus 2><lipid based nanoparticle><lipid nanoparticle><mAbs><mRNA><mRNA vaccine><mRNA-based vaccine><malaria transmission><malignancy><manufacture><meeting><meeting reports><meetings><member><microbial><microorganism><model of animal><monoclonal Abs><mucosal vaccine><multi-drug resistant><multi-drug resistant bacteria><multidrug resistant><multidrug resistant bacteria><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nCoV2><neoplasm/cancer><neutralizing antibody><new vaccines><next generation><next generation vaccines><novel vaccines><pathogen><pediatric><peer><peer-group atmosphere><peer-group environment><persistent infection><plasmocyte><post-doc><post-doctoral><post-doctoral trainee><posters><preparations><prevent><preventing><programs><research associates><resident memory T cell><response><scale up><secondary immune response><serious COVID><serious COVID-19><serious SARS-CoV-2><serious coronavirus disease><serious coronavirus disease 2019><serious severe acute respiratory syndrome coronavirus 2><severe COVID><severe COVID-19><severe COVID19><severe SARS-CoV-2><severe coronavirus disease><severe coronavirus disease 19><severe coronavirus disease 2019><severe severe acute respiratory syndrome coronavirus 2><skills><social role><structural biology><summit><symposia><symposium><technology platform><technology system><thymus derived lymphocyte><tissue resident memory T cell><transmission blocking><vaccination strategy><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine candidate><vaccine effectiveness><vaccine for cancer><vaccine for novel coronavirus><vaccine platform><vaccine-related research><vaccines against malaria><vaccinology><virtual><virus-like nanoparticles><viruslike particle><volunteer>